Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescent 5-HT1A antagonist [NAN-190] (AC129)
Cat.#: ASSD-129
Specifications
Description Fluorescent 5-HT1A serotonin receptor antagonist (apparent KD values are 8.75, 6.34 and 5.57 for 5-HT1A, 5-HT2A and 5-HT1B receptors respectively). Antagonizes the activity of serotonin, a 5-HT1A agonist. Synonyms 5HT1A-633-AN2 Size 50 μg Applications For imaging at the 5-HT1A receptor use solutions up to 200 nM. Molecule Weight 1025 Purity >97% Solubility Soluble in DMSO Excitation 633 nm Emission 650 nm Storage Store at -20° C Shipping Shipped at 4°C Important We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-140 A2B covalent ligand (AC140) 50 μg inquiry ASSD-169 Calcium Ionophore A23187 (AC169) 1mg, 5mg, 10 mg inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-137 CCR2 covalent NAM (AC137) 50 μg inquiry ASSD-113 Thionin acetate salt (AC113) 5 g inquiry ASSD-146 Pyronin Y (AC146) 1 g, 5g inquiry ASSD-213 Fluorescein 6-Maleimide (AC213) 25 mg, 250 mg inquiry ASSD-119 Fluorescent adenosine agonist [NECA] (AC119) 500 μg inquiry ASSD-118 BrdU (5-Bromo-2′-deoxyuridine) (AC118) 200 mg, 100 mg, 1 g, 5g inquiry ASSD-102 DAPI (AC102) 10 mg, 50 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket